Nektar Therapeutics NKTR
NASDAQ NKTR
$37.96 -0.31 (-0.81%)
As of: Oct 22, 2026 · 10:56 AM EDT

Nektar Therapeutics (NKTR) Long-Term Debt Issuances (2012)

Updated

Nektar Therapeutics (NKTR) reported Long-Term Debt Issuances of $241.26 million for FY2015.

Analysis

Nektar Therapeutics (NKTR) Long-Term Debt Issuances (2012) Analysis & Trends

  • Long-Term Debt Issuances has a three-year compound annual growth rate of 45.7% (FY2012 to FY2015).
  • The FY2015 figure ranks as the lowest annual Long-Term Debt Issuances since FY2012.
  • According to Business Quant data, Long-Term Debt Issuances came in at $77.94 million in FY2012.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Issuance (Qtr)
1 Eli Lilly 1,167.56 Bn 1,136.14 Bn 19.71 Bn 8.94 Bn
2 Johnson & Johnson 635.76 Bn 554.29 Bn 17.26 Bn -
3 AbbVie 503.27 Bn 476.38 Bn 12.70 Bn -
4 Merck 377.51 Bn 331.89 Bn 12.21 Bn -
5 Novartis Ag 304.07 Bn 268.06 Bn 11.24 Bn 1.98 Bn
6 Astrazeneca 267.53 Bn 241.22 Bn 12.86 Bn -
7 Amgen 242.06 Bn 197.46 Bn 7.24 Bn -
8 Gilead Sciences 194.26 Bn 168.46 Bn 6.22 Bn -
9 Pfizer 172.62 Bn 119.27 Bn 10.94 Bn -
10 Nektar Therapeutics 1.26 Bn -504.89 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2012 -66,000.00
API Access

Nektar Therapeutics Long-Term Debt Issuances API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-issuances&ticker=NKTR&period=max&api_key=YOUR_API_KEY